Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=5
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=5
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=5
PubPharm (7.414)
41
Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma : Phase II Trial of Sequential Treatment of Multiple Myeloma With Antibody Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
42
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions : Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
43
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) : A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Mezigdomide (CC-92480), Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-1
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
44
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects : A Phase I Study to Compare the Pharmacokinetic Characteristics, Safety, Tolerability, and Immunogenicity (Randomized, Double-blind, Parallel Controlled) of HLX15 With Daratumumab Injection in Healthy Chinese Male Subjects
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
45
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma : A Multicenter, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBL-034 in Patients With Relapsed/Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
46
A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma : A Phase 1b/2a, Multicenter, Open-label Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
47
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma : A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
48
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma. : A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
49
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies : A Pilot Study of Lenalidomide Alternating With Ipilimumab Post Allogeneic and Autologous Stem Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
50
A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma : A Phase II Study of Elotuzumab in Combination With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[742]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Multiple Myeloma
Medienart
7.367
Aufsätze
6.089
E-Ressourcen
6.066
E-Artikel
1.301
Gedruckte Aufsätze
47
Bücher
24
Gedruckte Bücher
23
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
3.159
ClinicalTrials.gov
1.401
Reactions weekly
800
Inpharma weekly
269
Annals of hematology
175
PharmacoEconomics & outcomes news
88
International journal of hematology
63
Drugs
49
Inpharma
43
BMC cancer
36
Current treatment options in oncology
30
Current hematologic malignancy reports
27
Journal of cancer research and clinical oncology
26
Journal of medical case reports
22
Cancer chemotherapy and pharmacology
21
Digestive diseases and sciences
20
Journal for ImmunoTherapy of Cancer
19
PharmacoEconomics
18
Drugs & aging
17
European journal of nuclear medicine and molecu...
17
Journal of hematology & oncology
Alle anzeigen ...
weniger ...
Thema
Multiple Myeloma
3.159
610
2.704
Study Type: Interventional
2.644
Neoplasms, Plasma Cell
1.336
Myeloma
1.194
Recruitment Status: Completed
955
Phase: Phase 2
791
Medical Condition: Multiple Myeloma
720
Recruitment Status: Recruiting
705
Bortezomib
657
Phase: Phase 1
587
Thalidomide
495
Dexamethasone
466
Lymphoma
440
Recruitment Status: Active, not recruiting
418
Study Type: Observational
367
Recruitment Status: Terminated
325
Zoledronic Acid
324
Leukemia
311
Lenalidomide
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.165
2020-
2.497
2010-2019
1.538
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.390
Englisch
11
Chinesisch
9
Deutsch
3
Russisch
3
Spanisch
3
Ukrainisch
2
Persisch
2
Portugiesisch
1
Französisch
1
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...